Before you can access ASH's online program, you must agree to the following:
Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

Pioneers In Hematologic Malignancies

Sunday, December 7, 2008: 11:00 AM-12:30 PM
303-305-307 - South (Moscone Center)
Moderator:
Nadia Sutherland, MD
Co-chairs:
Volker Diehl, MD, PhD , Robert A. Kyle, MD and Janet D. Rowley, MD

Volker Diehl, MD
Dr. Volker Diehl is well known for his pioneering research on Hodgkin disease. His scientific achievements include the discovery of the causative role of the Epstein-Barr virus in infectious mononucleosis and the study of the virus’ association with Hodgkin disease. He also cultured the first notoriously fragile Hodgkin cell lines and led the development of BEACOPP, a chemotherapy regimen for the treatment of Hodgkin disease. Dr. Diehl has received much recognition for his work, including the German Johann Georg Zimmermann prize for cancer research, and is Chairman of the German Hodgkin Lymphoma Study Group, one of the largest Hodgkin studies in the world, which he founded in 1978. He is also an honorary member of the Moscow Academy of Medicine, the European Society of Radio-Oncology, the Belgian Society of Radio-Oncology, the German Society of Radio-Oncology, the Hungarian Society of Hematology, and the German Society of Internal Medicine.

Robert Kyle, MD
Throughout his career, Dr. Robert Kyle has published more than 1,850 scientific papers and abstracts on myeloma, and much of today’s medical knowledge about the disease is largely due to his work. Among his several honors, Dr. Kyle was the first recipient of the Waldenstrom’s Award in 2001. He was the recipient of the Karnofsky Award and Lecture by the American Society of Clinical Oncology in 2007. He is currently Director of the International Myeloma Foundation’s Scientific Advisory Board and a professor at the Mayo Medical School in Rochester, MN.

Janet D. Rowley, MD
Dr. Janet Rowley is internationally recognized for her work on genetic abnormalities in leukemia and lymphoma. In 1972, she discovered a chromosomal translocation in acute myelogenous leukemia, the first time translocations were discovered in any human cancer. Dr. Rowley’s continuing research in this area has led to a better understanding of the pathogenesis, diagnosis, and treatment of cancer. Among her many honors, she has received two of ASH’s highest awards: the Dameshek Prize and Stratton Medal. Dr. Rowley is currently the Blum-Riese Distinguished Service Professor at the University of Chicago.

See more of: Pioneers in Hematology